Cargando…
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
BACKGROUND: In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as γ-H2AX. Formation of γ-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA doub...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731473/ https://www.ncbi.nlm.nih.gov/pubmed/26820970 http://dx.doi.org/10.1371/journal.pone.0147968 |
_version_ | 1782412548443734016 |
---|---|
author | Rasche, Ludwig Heiserich, Lisa Behrens, Janina Ruth Lenz, Klaus Pfuhl, Catherina Wakonig, Katharina Gieß, René Markus Freitag, Erik Eberle, Caroline Wuerfel, Jens Dörr, Jan Bauer, Peter Bellmann-Strobl, Judith Paul, Friedemann Roggenbuck, Dirk Ruprecht, Klemens |
author_facet | Rasche, Ludwig Heiserich, Lisa Behrens, Janina Ruth Lenz, Klaus Pfuhl, Catherina Wakonig, Katharina Gieß, René Markus Freitag, Erik Eberle, Caroline Wuerfel, Jens Dörr, Jan Bauer, Peter Bellmann-Strobl, Judith Paul, Friedemann Roggenbuck, Dirk Ruprecht, Klemens |
author_sort | Rasche, Ludwig |
collection | PubMed |
description | BACKGROUND: In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as γ-H2AX. Formation of γ-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA double-strand breaks. γ-H2AX expression in peripheral blood mononuclear cells (PBMCs) was recently proposed as a diagnostic and disease activity marker for multiple sclerosis (MS). OBJECTIVE: To evaluate the significance of γ-H2AX and 53BP1 foci in PBMCs as diagnostic and disease activity markers in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS) using automated γ-H2AX and 53BP1 foci detection. METHODS: Immunocytochemistry was performed on freshly isolated PBMCs of patients with CIS/early RRMS (n = 25) and healthy controls (n = 27) with γ-H2AX and 53BP1 specific antibodies. Nuclear γ-H2AX and 53BP1 foci were determined using a fully automated reading system, assessing the numbers of γ-H2AX and 53BP1 foci per total number of cells and the percentage of cells with foci. Patients underwent contrast enhanced 3 Tesla magnetic resonance imaging (MRI) and clinical examination including expanded disability status scale (EDSS) score. γ-H2AX and 53BP1 were also compared in previously frozen PBMCs of each 10 CIS/early RRMS patients with and without contrast enhancing lesions (CEL) and 10 healthy controls. RESULTS: The median (range) number of γ-H2AX (0.04 [0–0.5]) and 53BP1 (0.005 [0–0.2]) foci per cell in freshly isolated PBMCs across all study participants was low and similar to previously reported values of healthy individuals. For both, γ-H2AX and 53BP1, the cellular focus number as well as the percentage of positive cells did not differ between patients with CIS/RRMS and healthy controls. γ-H2AX and 53BP1 levels neither correlated with number nor volume of T2-weighted lesions on MRI, nor with the EDSS. Although γ-H2AX, but not 53BP1, levels were higher in previously frozen PBMCs of patients with than without CEL, γ-H2AX values of both groups overlapped and γ-H2AX did not correlate with the number or volume of CEL. CONCLUSION: γ-H2AX and 53BP1 foci do not seem to be promising diagnostic or disease activity biomarkers in patients with early MS. Lymphocytic DNA double-strand breaks are unlikely to play a major role in the pathophysiology of MS. |
format | Online Article Text |
id | pubmed-4731473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47314732016-02-04 Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study Rasche, Ludwig Heiserich, Lisa Behrens, Janina Ruth Lenz, Klaus Pfuhl, Catherina Wakonig, Katharina Gieß, René Markus Freitag, Erik Eberle, Caroline Wuerfel, Jens Dörr, Jan Bauer, Peter Bellmann-Strobl, Judith Paul, Friedemann Roggenbuck, Dirk Ruprecht, Klemens PLoS One Research Article BACKGROUND: In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as γ-H2AX. Formation of γ-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA double-strand breaks. γ-H2AX expression in peripheral blood mononuclear cells (PBMCs) was recently proposed as a diagnostic and disease activity marker for multiple sclerosis (MS). OBJECTIVE: To evaluate the significance of γ-H2AX and 53BP1 foci in PBMCs as diagnostic and disease activity markers in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS) using automated γ-H2AX and 53BP1 foci detection. METHODS: Immunocytochemistry was performed on freshly isolated PBMCs of patients with CIS/early RRMS (n = 25) and healthy controls (n = 27) with γ-H2AX and 53BP1 specific antibodies. Nuclear γ-H2AX and 53BP1 foci were determined using a fully automated reading system, assessing the numbers of γ-H2AX and 53BP1 foci per total number of cells and the percentage of cells with foci. Patients underwent contrast enhanced 3 Tesla magnetic resonance imaging (MRI) and clinical examination including expanded disability status scale (EDSS) score. γ-H2AX and 53BP1 were also compared in previously frozen PBMCs of each 10 CIS/early RRMS patients with and without contrast enhancing lesions (CEL) and 10 healthy controls. RESULTS: The median (range) number of γ-H2AX (0.04 [0–0.5]) and 53BP1 (0.005 [0–0.2]) foci per cell in freshly isolated PBMCs across all study participants was low and similar to previously reported values of healthy individuals. For both, γ-H2AX and 53BP1, the cellular focus number as well as the percentage of positive cells did not differ between patients with CIS/RRMS and healthy controls. γ-H2AX and 53BP1 levels neither correlated with number nor volume of T2-weighted lesions on MRI, nor with the EDSS. Although γ-H2AX, but not 53BP1, levels were higher in previously frozen PBMCs of patients with than without CEL, γ-H2AX values of both groups overlapped and γ-H2AX did not correlate with the number or volume of CEL. CONCLUSION: γ-H2AX and 53BP1 foci do not seem to be promising diagnostic or disease activity biomarkers in patients with early MS. Lymphocytic DNA double-strand breaks are unlikely to play a major role in the pathophysiology of MS. Public Library of Science 2016-01-28 /pmc/articles/PMC4731473/ /pubmed/26820970 http://dx.doi.org/10.1371/journal.pone.0147968 Text en © 2016 Rasche et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rasche, Ludwig Heiserich, Lisa Behrens, Janina Ruth Lenz, Klaus Pfuhl, Catherina Wakonig, Katharina Gieß, René Markus Freitag, Erik Eberle, Caroline Wuerfel, Jens Dörr, Jan Bauer, Peter Bellmann-Strobl, Judith Paul, Friedemann Roggenbuck, Dirk Ruprecht, Klemens Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study |
title | Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study |
title_full | Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study |
title_fullStr | Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study |
title_full_unstemmed | Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study |
title_short | Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study |
title_sort | analysis of lymphocytic dna damage in early multiple sclerosis by automated gamma-h2ax and 53bp1 foci detection: a case control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731473/ https://www.ncbi.nlm.nih.gov/pubmed/26820970 http://dx.doi.org/10.1371/journal.pone.0147968 |
work_keys_str_mv | AT rascheludwig analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT heiserichlisa analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT behrensjaninaruth analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT lenzklaus analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT pfuhlcatherina analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT wakonigkatharina analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT gießrenemarkus analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT freitagerik analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT eberlecaroline analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT wuerfeljens analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT dorrjan analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT bauerpeter analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT bellmannstrobljudith analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT paulfriedemann analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT roggenbuckdirk analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy AT ruprechtklemens analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy |